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Introduction 
 “It is a capital mistake to theorize before one has data.  Insensibly, one begins to twist 
facts to suit theories, instead of theories to suit facts” observed Sir Arthur Conan Doyle.  For 
Sherlock Holmes, this was insightful wisdom, but data voids mean that the pediatric intensivist 
currently has to diagnose and treat on the basis of what is both known and unknown.  The need 
to improve our empirical evidence-base and be clear when we are defaulting to precedent, 
assumption, or plausibility is increasingly acknowledged.[1]  This “Focus on Paediatrics” 
reviews what has been and what remains to be learned in several key topics. 
 
Tight Glycemic Control 
 Following the initial remarkable benefits demonstrated for critically ill adults treated with 
insulin to limit even mild hyperglycemia,[2-4] there was widespread uptake of tight glycemic 
control in both critically ill adults and children.  With additional data,[5] the pendulum soon 
swung back towards more moderate glucose control for critically ill adults.  Earlier this year, 
Agus and colleagues reported no difference in ICU-free days, organ dysfunction, or mortality for 
children receiving vasoactive support for hypotension and/or invasive mechanical ventilation 
randomized to glycemic targets of 4.4 to 6.1 mmol/L versus 8.3 to 10.0 mmol/L.[6]  This latest 
glucose trial minimized hypoglycemia using a computer-assisted algorithm but failed to 
reproduce earlier enthusiastic results reported for tight glycemic control in children,[2] similar to 
the SPECS [7] and CHiP studies.[8]  Following these studies, Yamada et al. published in 
Intensive Care Medicine a network meta-analysis demonstrating that, over time, cumulative 
results stabilized across multiple trials and trended toward the null hypothesis.[9]  The totality of 
data for paediatric patients now shows that mild glycemic control achieves similar clinical 
outcomes as tight control, with less risk of hypoglycemia. 
 
Acute Kidney Injury 
 In ICM in 2015, Ronco and Ricci reviewed the remarkable advances in experience and 
technology over the last 20 years that have led to the development of a new field of critical care 
nephrology for infants and children.[10]  This review was largely based on small, predominantly 
retrospective studies from a few centers.  In 2017, the AWARE investigators prospectively 
evaluated 4,683 pediatric patients admitted to 32 ICUs by KDIGO criteria for acute kidney 
injury (AKI).[11]  In total 26.9% developed AKI, including 11.6% with severe (KDIGO stage 2 
or 3) AKI, with a strong independent association with use of mechanical ventilation and death.  
This large, multicenter, prospective study allowed unique insight, independent from a large 
number of confounding variables, as to the incidence and association of AKI in pediatric critical 
illness. 
 
Sepsis 
 In 2017, the latest update to the American College of Critical Care Medicine (ACCM) 
Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock 
was published.[12, 13]  Although the literature review ended in year 2014—several years prior to 
ultimate publication—seven years had elapsed since the prior version was published.  Even so, 
the taskforce itself noted, “the changes recommended were few.”  Most of the interim data 
available had focused on improving implementation of prior guidelines.  Although this led to the 
inclusion of four bundles to address sepsis recognition, resuscitation, stabilization, and 
performance review, new data was scarce.  However, several recent studies have already begun 
to push the field of pediatric sepsis forward.  First, in ICM, paediatric investigators from 
ANZICS derived a pediatric sepsis score using PaO2:FiO2 ratio, need for invasive mechanical 
ventilation, systolic blood pressure, lactate, and pupillary response that predicted mortality with 
reasonable accuracy in the first hour of ICU admission.[14]  Such early prediction is vital, as the 
authors showed that about half of sepsis-associated deaths occurred within 48 hours of 
admission, a finding similarly reported in the United Kingdom and United States.[15, 16]  
Second, Matics and Sanchez-Pinto also used a large observational database to develop a pediatric 
version of the Sequential Organ Failure Assessment (SOFA) score, which was previously used 
by Sepsis-3 to operationalize organ dysfunction in adult sepsis.[17]  The new pSOFA score 
performed better than other organ dysfunction scores, and nearly two-thirds of deaths met the 
Sepsis-3 definition for septic shock. 
A common theme across Sepsis-3, the ANZICS study, and the Matics et al study is 
reliance on blood pressure measurements.  But what cut-points are most optimal for pediatric 
hypotension?  Ray et al. compared concurrently recorded invasive and non-invasive blood 
pressure measurements across 50,000 pairs and found that non-invasive measurements gave 
systematically lower readings for mean and diastolic values.[18]  How is one to determine which 
blood pressure targets are optimal in septic shock when it is not even clear how to best to 
measure?  Another troublesome topic is the role for low-dose corticosteroids in septic shock.  
Despite controversial results in adults for which the totality of data provide for a reasonable 
recommendation, there are is no high-level evidence for pediatric septic shock.[19]  Clearly a 
clinical trial is necessary.  Menon et al. tested the feasibility of randomizing children with septic 
shock to hydrocortisone versus placebo and found that a pragmatic study design enhanced 
enrollment but lack of equipoise among intensivists, as evidenced by frequent overall use of 
corticosteroids, was noted to be an important potential barrier.[20]  It seems that, even in the 
absence of strong data, strong opinions may be difficult to overcome.  Finally, although not 
sepsis, James and colleagues studied use of nitric oxide (NO) during cardiopulmonary bypass—
another systemic inflammatory insult—and found that patients randomized to NO had a lower 
incidence of cardiogenic shock and reduced length of stay, especially in neonates and complex 
heart disease.[21]  Perhaps ameliorating reperfusion injury is as important as reperfusion itself. 
 
Mechanical Ventilation 
 In ICM in 2017, the Paediatric Mechanical Ventilation Consensus Conference 
(PEMVECC) developed and voted on 152 recommendations about paediatric mechanical 
ventilation.[22]  In keeping with the theme of scarce evidence, randomised clinical trial data 
were available for only three topic areas and most recommendations were either deferred or 
based on low-to-moderate evidence.  Still, the synthesis of available data—and the areas devoid 
of data—is of monumental benefit to clinicians and investigators.  Moreover, the Oxy-PICU 
investigators described current practice of oxygenation targets in a PICU and showed, with high-
fidelity SpO2 data, that liberal oxygenation targets <95% are the general rule irrespective of the 
FiO2 or mean airway pressure used.[23]  These data pave the way for a trial of oxygenation 
targets in critically ill children.  The TRAMONTANE study randomized infants <6 months with 
moderate/severe bronchiolitis to either high-flow nasal cannula (HFNC) or continuous positive 
airway pressure (CPAP) with cross-over allowed.[24]  Overall, patients in both groups were 
rarely intubated, with similar rates of rescue using the alternative non-invasive modality, 
suggesting that clinician preference may be more important than the modality chosen even 
though initial randomization to HFNC was slightly less efficacious.  Finally, a review by Moreira 
and Sapru in ICM discuss the potential for targeted use of epithelial, endothelial, coagulation, 
and inflammatory biomarkers to treat children with acute lung disease, further emphasizing the 
complexity in data-driven approaches to mechanical ventilation and other novel lung 
therapies.[25] 
 
Pain and Sedation 
 A multidisciplinary taskforce published clinical recommendations for pain, sedation, 
withdrawal and delirium assessment in critically ill infants and children in ICM in 2016.  Similar 
to mechanical ventilation, the authors noted a limited literature with most recommendations 
based on few data.[26]  Addressing one aspect, Vet and colleagues compared protocolized 
sedation with versus without a daily sedation interruption and found no difference in ventilator-
free days or length stay but a higher mortality in the interruption arm.  Unfortunately, the study 
was terminated early for slow recruitment, hindering data quality.[27]   
 
Post-ICU Survivor Outcomes 
 In 2017, the long-awaited results of the therapeutic hypothermia after in-hospital cardiac 
arrest were published.[28]  Similar to the previously reported out-of-hospital THAPCA trial, 
there was no benefit for moderate hypothermia compared to controlled normothermia on survival 
with a good neurobehavioral outcome.  Of note, the investigators used the Vineland Adaptive 
Behavior Scale to measure their primary outcome with substantial caregiver reporting.  However, 
van Zellem et al. showed that parents and teachers systematically reported different levels of 
function following survival from cardiac arrest.[29]  Thus, even when outstanding attempts are 
made to collect longer-term morbidity outcomes, the most appropriate measures remain unclear.  
Finally, Verstraete and colleagues demonstrated that there may also be risk factors right under 
our noses that we fail to consider when they showed that environmental phthalate exposure 
leaching from indwelling medical devices was common in PICU patients, with higher levels 
associated with long-term attention deficits.[30] 
 
Conclusions 
Sherlock Holmes’ skill was to solve challenging cases by finding clarity despite 
seemingly limited data.  Paediatric intensivists are arguably faced with similar challenges, but 
without necessarily the same genius. Holmes understood “there is nothing like first-hand 
evidence.” The work we highlight here (Table) may assist us non-sleuths to make better 
decisions. 
 
  
Table:  Select Recent Pediatric Critical Care Trials  
Trial Population N / Sites Intervention Control Outcome 
HALF-PINT [6] 
PICU, non-
cardiac diasease 
713 / 32 
Tight glycemic 
control 
Mild glycemic 
control 
No difference in ICU-free 
days 
THAPCA [28] 
In-hospital 
cardiac arrest 
329 / 37 
Moderate 
hypothermia (33 
°C) 
Controlled 
normothermia 
(36.8 °C) 
No difference in 1-year 
survival with good function 
PRBC 
transfusion [31] 
PICU 180 /1 
Restrictive 
transfusion (Hgb 
<7 g/dL) 
Liberal 
transfusion 
(Hgb <10 g/dL) 
Improved hemodynamics 
with restrictive transfusion 
PRBC 
transfusion [32] 
CICU 162 / 1 
Restrictive 
transfusion (Hgb 
<7 g/dL) 
Liberal 
transfusion 
(Hgb <9.5 g/dL) 
No difference in perfusion 
or clinical outcomes 
TRAMONTANE 
[24] 
Moderate-
severe 
bronchiolitis 
142 / 5 
HFNC 2 
L/kg/min 
CPAP 7 cm 
H2O 
Higher failure rate with 
initial HFNC 
Fluid bolus [33] ED, PICU 96 / 1 
15-20 minute 
bolus 
5-10 minute 
bolus 
Lower mechanical 
ventilation in 15-20 minute 
bolus group 
Hydrocortisone 
[20] 
PICU 57 / 7 Hydrocortisone Placebo Feasible to enroll in RCT 
PEPaNIC [34] PICU 1440 / 3 
Early parenteral 
nutrition (<1 
day) 
Late parenteral 
nutrition (>7 
days) 
Improved outcomes in late 
parenteral nutrition group 
Nitric oxide [21] CPB 101 / 1 
Standard gas + 
nitric oxide 
Standard gas 
Reduced cardiogenic shock 
in nitric oxide group 
Sedation [27] PICU 129 / 3 
Protocolized 
sedation + daily 
sedation 
interruption 
Protocolized 
sedation 
Increased mortality with 
daily sedation interruption 
 
HALF-PINT, Heart and Lung Failure-Pediatric Insulin Titration; THAPCA, Therapeutic 
Hypothermia After Pediatric Cardiac Arrest; PRBC, packed red blood cell; TRAMONTANE, 
High flow nasal cannula versus nasal continuous positive airway pressure for the initial 
respiratory management of acute viral bronchiolitis; PEPaNIC, Early versus Late Parenteral 
Nutrition in the Pediatric Intensive Care Unit; PICU, pediatric intensive care unit; CICU, cardiac 
intensive care unit, ED, emergency department; CPB, cardiopulmonary bypass; HFNC, high-
flow nasal cannula; CPAP, continuous positive early pressure; RCT, randomized controlled trial 
 
Reference:  http://picutrials.net 
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